We recommend that you upgrade to the latest version of your browser.
logo Helse Bergen

Eva Ringdal Pedersen: Publications 2018-2023

  1. Bahlmann E, Einarsen E, Cramariuc D, Pedersen ER, Rossebø AB, Midtbø H, Willems S, Gerdts Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area. Open Heart. 2022 Nov;9(2):e002159. doi: 10.1136/openhrt-2022 002159.PMID: 3642808.
  2. Berge CA, Eskerud I, Almeland EB, Larsen TH, Pedersen ER, Rotevatn S, Lønnebakken MT. Relationship between hypertension and non-obstructive coronary artery disease in chronic coronary syndrome (the NORIC registry).PLoS One. 2022 Jan 2;17(1):e0262290. doi: 10.1371/journal.pone.0262290. eCollection 2022
  3. Bjørnestad EØ, Dhar I, Svingen GFT, Pedersen ER, Svenningsson MM, Tell GS, Ueland PM, Ørn S, Sulo G, Laaksonen R, Nygård Trimethyllysine predicts all-cause and cardiovascular mortality in community-dwelling adults and patients with coronary heart disease.Eur Heart J Open. 2021 Jul 16;1(1):oeab007. doi: 10.1093/ehjopen/oeab007. eCollection 2021 Aug.
  4. Bjørnestad EØ, Dhar I, Svingen GFT, Pedersen ER, Ørn S, Svenningsson MM, Tell GS, Ueland PM, Sulo G, Laaksonen R, Nygård O. Circulating trimethylamine N-oxide levels do not predict 10-year survival in patients with or without coronary heart disease. J Intern Med. 2022 Aug 2. doi: 10.1111/joim.13550. 
  5. Bjørnestad EØ, Olset H, Dhar I, Løland K, Pedersen EKR, Svingen GFT, Svardal A, Berge RK, Ueland PM, Tell GS, Nilsen DWT, Nordrehaug JE, Nygaard E, Nygård O. Circulating trimethyllysine and risk of acute myocardial infarction in patients with suspected stable coronary heart disease. J Intern Med. 2020 Apr 9. doi: 10.1111/joim.13067
  6. Dhar I, Svingen GFT, Pedersen ER, DeBatt B, Ulvik A, Strand E, Ueland PM, Bønaa Kh, Gregory JF, Nygård O. Plasma cystathionine and risk of acute myocardial infarction among patient with coronary heart disease: Results from two independent cohorts. Int J Cardiol 2018. 266: 24-30
  7. Dhar I Svingen GFT, Pedersen ER, Ulvik A, Bjørnestad EØ, Dankel SN, Dierkes J, Mellgren G, Nygård O. Physical activity and risk of all-cause mortality in patients with stable coronary heart disease: effect modification by β-blocker treatment.Int J Cardiol Cardiovasc Risk Prev. 2022 (accepted manuscript).
  8. Degerud E, Nygård O, de Vogek S, Hoff R, Svingen GFT, Pedersen ER, Nilsen DWT, Nordrehaug JE, Midttun Ø, Ueland PM, Dierkes J. Plasma 25- Hydroxyvitamin D and mortality in patients with suspected stable angina pectoris, J Cin Endocrinol Metab. 2018. 103:1161-1170.
  9. Hilvo M, Meikle PJ, Pedersen ER, Tell GS, Dhar I, Brenner H, Schöttker B, Lääperi M, Kauhanen D, Koistinen KM, Jylhä A, Huynh K, Mellett NA, Tonkin AM, Sullivan DR, Simes J, Nestel P, Koenig W, Rothenbacher D, Nygård O, Laaksonen R. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. Eur Heart J. 2020 Jan 14;41(3):371-380. doi:
  10. 1093/eurheartj/ehz387 Lund A, Nordrehaug JE, Slettom G, Solvang SH, Pedersen EK, Midttun Ø, Ulvik A, Ueland PM, Nygård O, Giil LM. Plasma kynurenines and risk of Heart failure. Plos One. 2020. DOI: 10.1371/journal.pone.0227365.
  11. McCann A, Giil LM, Ulvik A, Seifert R, Rebnord EW, Pedersen ER, Svingen GFT, Meyer K, Strand E, Dankel S, Ueland PM, Nygård OK. Plasma Amino Acids and Incident Type 2 Diabetes in Patients With Coronary Artery Disease.Diabetes Care. 2019 Jul;42(7):1225-1233. doi: 10.2337/dc18-2217. Epub 2019 Apr 29.
  12. Myrmel GMS, Steiro OT, Tjora HL, Langørgen J, Bjørneklett R, Skadberg Ø, Bonarjee VVS, Mjelva ØR, Pedersen EKR, Vikenes K, Omland T, Aakre KM. Growth Differentiation Factor 15: A Prognostic Marker in Patients with Acute Chest Pain without Acute Myocardial Infarction. Clin Chem. 2023 Jun 1;69(6):649-660. doi: 10.1093/clinchem/
  13. Olsen T, Vinknes KJ, Svingen GF, Pedersen ER, Dahr I, Tell GS, Blomhoff R, Ueland PM, Midttun Ø, Refsum H, Nygård O. The risk association of plasma total homocysteine with acute myocardial infarction is modified by vitamin A. Eur J Prev Cardiol. 2018. 2018 Oct;25(15):1612-1620. doi: 10.1177/2047487318788587. Epub 2018 Jul 17.PMID: 30014716
  14. Olsen T, Vinknes KJ, Blomhoff R, Lysne V, Midttun Ø, Dhar I, Ueland PM, Svingen GFT, Pedersen EKR, Drevon CA, Refsum H, Nygård OK. Creatinine, total cysteine and uric acid are associated with serum retinol in patients with cardiovascular disease. Eur J Nutr. 2019 Sep 9. doi: 10.1007/s00394-019-02086-2.
  15. Pedersen ER, Hovland S, Karaji I, Berge C, Mohamed Ali A, Lekven OC, Kuiper KJ, Rotevatn S, Larsen TH. Coronary calcium score in the initial evaluation of suspected coronary artery disease. Heart. 2023 Apr 12;109(9):695-701. doi: 10.1136/heartjnl-2022-321682.PMID: 36549683
  16. Rebnord  EW, Strand E, Pedersen ER. Response to Letter to the Editor: Serum Carnitine Metabolites and  Incident Type 2 Diabetes in Patients with Suspected Stable Angina Pectoris,  J Clin Endocrinol Metab 2018;103(11):4039. doi: 10.1210/jc.2018-01647v;103:1033-1041
  17. Storesund SK, Karaji I, Strand E, Svardal A, Lønnebakken MT, Berge RK, Tveitevåg Svingen GF, Nygård OK, Pedersen ER. Even chained acylcarnitines predict long-term cardiovascular prognosis in patients with chest pain and non-obstructive coronary artery disease. Int J Cardiol Cardiovasc Risk Prev. 2022 May 17;14:200134. doi: 10.1016/j.ijcrp.2022.200134. eCollection 2022 Sep.
  18. Svenningsson MM, Svingen GFT, Lysne V, Ueland PM, Tell GS, Pedersen ER, Dhar I, Nilsen DW, Nygård O.Transsulfuration metabolites and the association with incident atrial fibrillation - An observational cohort study among Norwegian patients with stable angina pectoris. Int J Cardiol. 2020 Oct 15;317:75-80. doi: 10.1016/j.ijcard.2020.05.010. Epub 2020 May 8.PMID: 32389762 
  19. Svingen GFT, Zuo H, Ueland PM, Seifert R, Løland KH, Pedersen ER, Schuster P, Karlsson T, Tell GS, Schartum-Hansen H, Olset H, Svenningson M, Strand E, Nilsen DW, Nordrehaug JE, Dahr I, Nygård O. Increased plasma trimethylamine -N-oxide is associated with incident atrial fibrillation. Int J Cardiol 2018. 15;267:100-106.
  20. Vavik V, Aakre KM, Pedersen EKR, Svingen GFT Tell GS, Nygård O, Vikenes K The association between serum high-sensitivity cardiac troponin T and acute myocardial infarction in patients with suspected chronic coronary syndrome is modified by body mass index. International Journal of Cardiology Cardiovascular Risk and Prevention2021-12 | Journal article. DOI: 10.1016/j.ijcrp.2021.200109
  21. Vavik V. Pedersen ER, Svingen GFT, Tell GS, Schartum-Hansen H, Aakre KM, Nygård O,Vikenes K. Usefullness of higer levels of cardiac troponin T in patients with stable angina pectoris to predict risk of acute myocardial infarction. Am J Cardiol 2018. 122(7); 1142-1147
  22. Vavik V, Pedersen ER, Svingen GFT, Solheim E, Aakre KM, Tell GS, Nygård O, Vikenes K. Systemic cardiac Troponin T is associated with incident atrial fibrillation among patients with suspected stable angina pectoris. Am J Cardiol 2020. 127;30-35.
  23. Zuo H. Nygård N, Ueland PM, Vollset SE, Svingen GFT, Pedersen ER, Midttun Ø, Meyer K, Plasma concentrations and dietary intakes of choline and betaine in association with atrial fibrillation risk: Results from 3 prospective cohorts with different health profiles. J Am Heart Assoc. 2018. Apr 12; 7(8). pii:e008190.   doi:10.1161/JAHA117.008190.
  24. Zuo H, Nygård O, Ueland PM, Vollset SE, Svingen GFT, Pedersen ER, Midttun Ø, Meyer K, Nordrehaug JE, Nilsen DW, Tell GS. Associations of plasma netopterin with risk of inpatient hospital diagnosis of atrial fibrillation: results from two prospective cohort studies. J int Med 2018. 283:578-587.

 

 


 

 

Last updated 2/12/2024